Portal Veterinary medicinal products

ANMV has updated its procedure for managing quality defects and batch recalls in veterinary medicines. A quality defect observed on a veterinary medicinal product during marketing must be declared to ANMV and assessed by both the manufacturer concerned and ANMV. The procedure for managing quality defects and batch recalls describes, step by step, the steps involved in declaring and assessing a quality defect, right up to the management of a possible batch recall. This procedure has just been updated to incorporate the provisions of European regulation 2019/6. It also presents an evolution of the quality defect rating grid for declared veterinary medicinal products. This rating makes it possible to assign a criticality level to the quality defect detected, and thus to guide the level of batch recall when it is deemed necessary. See the procedure

Cases of foot-and-mouth disease were detected on a water buffalo farm in Germany on 10 January. This is the first outbreak in Germany since 1988, and in the European Union since 2011. Although no other cases have been detected so far, ANSES, through its Laboratory for Animal Health, stands ready to take action to prevent the spread of the disease. This article explains its role and missions.

Type D influenza is a flu virus that mainly affects cattle. However, ANSES's Ploufragan-Plouzané-Niort Laboratory recently isolated the virus in pigs for the first time in France. This crossing between species illustrates the importance of research aimed at improving the study of a possible risk of virus transmission to humans.

Around 60 cases of humans being poisoned by medication containing pergolide intended for horses have been reported since 2012. Because of the small size of the tablets and the long duration of the treatment, the risk of accidental ingestion is particularly high. Here is a reminder of the recommendations for avoiding accidents and taking appropriate action in the event of accidental ingestion.